Sojitz — Full Portfolio
3 tracked investments · listed companies and verified rows first
Synplogen is a synthetic biology startup spun out of Kobe University that offers custom artificial gene synthesis and DNA library construction services using its proprietary OGAB and Combinatorial-OGAB (Combi-OGAB) DNA assembly methods.
BiotechDeep TechMedical DevicesKobe, JP
柘植謙爾(取締役 / Founder (Executive Research Fellow))山本一彦(代表取締役社長 兼 CEO)山田尚之(常務取締役 CTO)岩田清和(取締役 COO)齋藤俊介(取締役 医療ビジネスユニット長)
Co-investorsi-nest capitalKobe University Capital
Tacta provides custom-built technology solutions to address complex business challenges for enterprise clients.
Developer ToolsEnterprise SoftwareBrussels, BE
Co-investorsProvectus Capital PartnersAmerica's Frontier FundB CapitalMatter Venture PartnersSBVASoftBank Group+2 more
Venice, US
Paul Eremenko(Executive Officer, Director)
Co-investorsFourth RealmTrucks VCAirbus VenturesHAWKTAILMitsubishi HC CapitalTencent Holdings+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.